Core chemotype diversification in the HIV-1 entry inhibitor class using field-based bioisosteric replacement.
Core chemotype diversification in the HIV-1 entry inhibitor class using field-based bioisosteric replacement.
复制标题
DOI：
10.1016/j.bmcl.2015.10.080
复制
发表时间：
2016-01-01
影响因子：
2.7
通讯作者：
Cocklin S
中科院分区：
文献类型：
--
作者：
Tuyishime M;Lawrence R;Cocklin S
仍然需要新的HIV-1复制抑制剂，抑制HIV-1进入是一种非常有吸引力的治疗方法。使用基于场的生物电子等排替代，我们进一步扩展了可用于HIV-1进入抑制剂类开发的化学型。此外，使用基于场的差异分析的化合物，3D结构-活性关系的推导，这将是有用的，在这些抑制剂的进一步发展，走向临床实用。
Demand remains for new inhibitors of HIV-1 replication and the inhibition of HIV-1 entry is an extremely attractive therapeutic approach. Using field-based bioisosteric replacements, we have further extended the chemotypes available for development in the HIV-1 entry inhibitor class. Moreover, using field-based disparity analysis of the compounds, 3D structure-activity relationships were derived that will be useful in the further development of these inhibitors towards clinical utility.